Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s00262-014-1571-6
Published Online: 2014-06-20
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
De Keersmaecker, Brenda
Fostier, Karel
Corthals, Jurgen
Wilgenhof, Sofie
Heirman, Carlo
Aerts, Joeri L.
Thielemans, Kris
Schots, Rik
Text and Data Mining valid from 2014-06-20